1 domain / 2 areas / 1 specialization
Psychedelic Science Funders Collaborative
Data updated
Collaborative funding network coordinating philanthropy and grant strategy for psychedelic science initiatives.
Foundations & Philanthropy Snapshot
Grant-Making OrganizationsClassification
Syndicate / Collaborative Fund
Geography
Global
Coverage
Global
Last Verified
Apr 10, 2026
Funding Focus Areas
Support Types
Verification
Verified
Psychedelic Focus
Explicit Psychedelic Focus
Engagement Status
Active
Recorded Funding Activities
Multidisciplinary Association for Psychedelic Studies (MAPS)
May 29, 2019
grant - Grant for MDMA-assisted psychotherapy for PTSD (GMP MDMA production, EMA Phase 2/3 trials, therapist training) - $4,140,000
Allocation: $2.9M GMP-grade MDMA production; $1.1M EMA-regulated Phase 2/3 PTSD trials; $50k advisory (Dr Atul Pande); $50k staff salaries; $40k therapy training for communities of colour in Kentucky. PSFC EIN 82-4139859.
MAPS Receives $4,140,000 Grant from Psychedelic Science Funders Collaborative (PSFC)Multidisciplinary Association for Psychedelic Studies (MAPS)
Sep 1, 2020
program-funding - Capstone Campaign - joint MAPS/PSFC fundraising for MDMA-assisted therapy Phase 3 / FDA approval - $30 million raised
PSFC co-ran the Capstone Campaign (launched March 2020) with MAPS, mobilising $30M in under six months from 2,500+ donors (incl. Steven & Alexandra Cohen Foundation $5M, Tim Ferriss $1M plus $10M match, Parsons $2M, George Sarlo $1M) to fund Phase 3 MDMA-assisted psychotherapy for PTSD.
Psychedelic Research Fundraising Campaign Attracts $30 Million in Donations in 6 Months - The Bob and Renee Parsons FoundationSource Evidence
Quick Facts
- Website
- Visit